Health
Autoimmune cell therapy trials face growing safety scrutiny after patient deaths
Recent patient fatalities in early-stage clinical trials highlight persistent safety risks and uncertainties surrounding emerging cell and CAR-T therapies for autoimmune conditions.
AI · grounded4 of 6 claims single-sourced